Abstract
BACKGROUND: The assessment of prognosis is an important issue in cystic fibrosis. The prognostic value of exercise testing in comparison with other predictors of mortality was examined. METHODS: Ninety two adult patients with cystic fibrosis performed progressive maximal exercise tests and outcome was assessed at five years. The results of exercise testing were examined along with spirometric values, age, sex, body mass index (BMI), and sputum culture. RESULTS: Twenty two subjects died during the five year follow up period and 67 survived. Five subjects received a lung transplant and were excluded from the analysis. There were significant differences between those who survived and those who died: mean (SE) forced expiratory volume in one second (FEV1) 68.9 (2.7) versus 39.7 (3.5)% predicted, BMI 19.0 (0.3) versus 17.1 (0.4) kg/m2, peak oxygen uptake (VO2 peak) 66.6 (2.2) versus (53.7) (3.7)% predicted, peak work rate (Wpeak) 89.4 (3.8) versus 71.2 (5.5)% predicted, peak minute ventilation (VEpeak) 51.3 (2.0) versus 43.3 (3.1) 1/min, and ventilatory equivalent for oxygen (VE/VO2) 32.4 (0.6) versus 38.7 (1.7). Age, sex, oxygen saturation and Burkholderia cepacia colonisation were not found to be significant predictors of mortality. When significant independent factors were entered into a multivariate logistic regression model only FEV1 was found to be a significant correlate of mortality. A cutoff for FEV1 of 55% predicted gave the best combination of specificity and sensitivity with 54% of those below this value dying within five years and 96% of those above it surviving. CONCLUSIONS: The results of maximal exercise testing are correlated with survival but they are not better than the FEV1 as prognostic indicators.
Full Text
The Full Text of this article is available as a PDF (120.8 KB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Corey M., McLaughlin F. J., Williams M., Levison H. A comparison of survival, growth, and pulmonary function in patients with cystic fibrosis in Boston and Toronto. J Clin Epidemiol. 1988;41(6):583–591. doi: 10.1016/0895-4356(88)90063-7. [DOI] [PubMed] [Google Scholar]
- FitzSimmons S. C. The changing epidemiology of cystic fibrosis. J Pediatr. 1993 Jan;122(1):1–9. doi: 10.1016/s0022-3476(05)83478-x. [DOI] [PubMed] [Google Scholar]
- Godfrey S., Mearns M. Pulmonary function and response to exercise in cystic fibrosis. Arch Dis Child. 1971 Apr;46(246):144–151. doi: 10.1136/adc.46.246.144. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Huang N. N., Schidlow D. V., Szatrowski T. H., Palmer J., Laraya-Cuasay L. R., Yeung W., Hardy K., Quitell L., Fiel S. Clinical features, survival rate, and prognostic factors in young adults with cystic fibrosis. Am J Med. 1987 May;82(5):871–879. doi: 10.1016/0002-9343(87)90147-1. [DOI] [PubMed] [Google Scholar]
- Kerem E., Reisman J., Corey M., Canny G. J., Levison H. Prediction of mortality in patients with cystic fibrosis. N Engl J Med. 1992 Apr 30;326(18):1187–1191. doi: 10.1056/NEJM199204303261804. [DOI] [PubMed] [Google Scholar]
- Knudson R. J., Lebowitz M. D., Holberg C. J., Burrows B. Changes in the normal maximal expiratory flow-volume curve with growth and aging. Am Rev Respir Dis. 1983 Jun;127(6):725–734. doi: 10.1164/arrd.1983.127.6.725. [DOI] [PubMed] [Google Scholar]
- Lewin L. O., Byard P. J., Davis P. B. Effect of Pseudomonas cepacia colonization on survival and pulmonary function of cystic fibrosis patients. J Clin Epidemiol. 1990;43(2):125–131. doi: 10.1016/0895-4356(90)90175-o. [DOI] [PubMed] [Google Scholar]
- Marcotte J. E., Grisdale R. K., Levison H., Coates A. L., Canny G. J. Multiple factors limit exercise capacity in cystic fibrosis. Pediatr Pulmonol. 1986 Sep-Oct;2(5):274–281. doi: 10.1002/ppul.1950020505. [DOI] [PubMed] [Google Scholar]
- Nixon P. A., Orenstein D. M., Kelsey S. F., Doershuk C. F. The prognostic value of exercise testing in patients with cystic fibrosis. N Engl J Med. 1992 Dec 17;327(25):1785–1788. doi: 10.1056/NEJM199212173272504. [DOI] [PubMed] [Google Scholar]
- Penketh A. R., Wise A., Mearns M. B., Hodson M. E., Batten J. C. Cystic fibrosis in adolescents and adults. Thorax. 1987 Jul;42(7):526–532. doi: 10.1136/thx.42.7.526. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Sharples L., Hathaway T., Dennis C., Caine N., Higenbottam T., Wallwork J. Prognosis of patients with cystic fibrosis awaiting heart and lung transplantation. J Heart Lung Transplant. 1993 Jul-Aug;12(4):669–674. [PubMed] [Google Scholar]
- Zinman R., Corey M., Coates A. L., Canny G. J., Connolly J., Levison H., Beaudry P. H. Nocturnal home oxygen in the treatment of hypoxemic cystic fibrosis patients. J Pediatr. 1989 Mar;114(3):368–377. doi: 10.1016/s0022-3476(89)80553-0. [DOI] [PubMed] [Google Scholar]